Dentsply Sirona Inc. Class Action Lawsuit - XRAY

Company
Dentsply Sirona Inc. (NASDAQ: XRAY)
Lead Plaintiff Deadline
August 1, 2022 (Expired)
Class Period
June 9, 2021 - May 9, 2022

Expired

Lead Plaintiff Deadline

Aug 1, 2022

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

According to the filed complaint, defendants orchestrated a scheme to inflate Dentsply’s revenue and earnings by manipulating the Company's accounting for a distributor rebate program so that senior executives would be eligible for significant cash and stock-based incentive compensation. In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the class period. As a result of defendants’ misrepresentations, Dentsply’s common stock traded at artificially inflated prices during the class period.

Eligibility

In order to be eligible to join the XRAY class action lawsuit, you must have incurred a loss on shares of Dentsply purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Dentsply during the relevant time frame or pursuant to the relevant offering(s), you have until August 1, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Dentsply Sirona Inc. Class Action Lawsuit Details

Levi & Korsinsky, LLP announces that a XRAY class action lawsuit has been filed on behalf of investors who purchased Dentsply Sirona Inc. (XRAY) common stock between June 9, 2021, and May 9, 2022, inclusive. For more on the XRAY Lawsuit please contact us today. According to the filed complaint, defendants orchestrated a scheme to inflate Dentsply’s revenue and earnings by manipulating the Company's accounting for a distributor rebate program so that senior executives would be eligible for significant cash and stock-based incentive compensation. In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the class period. As a result of defendants’ misrepresentations, Dentsply’s common stock traded at artificially inflated prices during the class period. If you suffered a loss in Dentsply Sirona Inc. you have until August 1, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP